(MENAFNEditorial) iCrowdNewswire - Aug 24, 2017
Latest report on colorectal cancer market of 74 pages now added by a leading business intelligence provider to MarketReportsOnline.com database.
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that has the ability to invade or spread to other parts of the body.
Complete report on colorectal cancer market spread across 74 pages with providing 4 company profiles, 4 tables and 46 charts is now available at .
Signs and symptoms for this cancer may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time. The current screening regime for this disease comprises of gFOBT, FIT, flexible Sigmoidoscopy, Colonoscopy and others. Further, the treatment for CRC is limited to surgery, chemotherapy and radiotherapy or adjuvant therapies.
The global CRC market would be driven by factors such as rising geriatric population, better reimbursement policies, growing number of obese people and others. However, the dynamics such as stringent regulatory norms, side effects of therapies and high cost of screening tests or drugs are expected to act as a threat for market's growth. Rising awareness regarding the incidence of CRC and importance of diagnosis has propelled higher compliance with regular tests. Further, in order to harness the market potential, various companies are involved in developing lesser invasive and easy to use screening methods.
Purchase a copy of this 'Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025) research report at USD 800 (Single User License) .
The report 'Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025) provides a comprehensive study of global market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth. The global market is highly competitive consisting of several large enterprises including Bayer AG, Roche Holding AG, Merck & Co., Inc. and Eli Lilly and Company. The competitive landscape of the respective market, along with the company profiles of leading players are discussed detail in report.
Few Points from List of Tables & Charts Provided in Colorectal Cancer Market:
List of Tables
Revenue and Market Cap. Comparison (2016)
DNA based CRC Screening Tests Comparison (2016)
Allergan Plc. Body Contouring Key Product Comparison (2017)
Number of Products in Pipeline by Segments (2016)
List of Charts
Stages of Colorectal Cancer
Treatment Option for Colorectal Cancer
Global Cancer Diagnostics Market Forecast by Value (2021-2025)
Global CRC Screening Patient Volume Forecast (2021-2025)
Global CRC Screening Patient Volume by Region (2021)
Global C-Scan Cap Revenue Forecast (2021-2025)
Global CRC Patients on Drugs by Volume (2021-2025)
Global CRC Patients on Drugs by Region (2021)
Global CRC Patients on Drugs by Segments (2021)
Global Modufolin Revenue Forecast by Value (2021-2025)
Explore more latest reports on pharmaceuticals market at .
Contact Information:
Hrishikesh Patwardhan
Tel: + 1 888 391 5441
E-mail:
MENAFN2408201700703403ID1095771186
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.